FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment
- PMID: 17885356
- DOI: 10.1097/RLU.0b013e318148b467
FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment
Abstract
We report 2 patients with chronic myeloid leukemia in the chronic phase showing diffusely increased F-18 fluorodeoxyglucose (FDG) uptake in the bone marrow before treatment. Follow-up FDG positron emission tomography (PET) scans were performed in a patient after cessation of treatment and in the other under treatment. Both FDG PET findings showed reduced FDG uptake in the bone marrow. A series of these FDG PET findings suggest the usefulness of FDG PET for the diagnosis and monitoring of chronic myeloid leukemia after treatment.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
